Brief Report(s)
Vol. 8 (2020)
Post-COVID oncology
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 30 June 2020
401
Views
276
Downloads
Authors
Objectives: To analyse the organisational changes adopted by the Oncology SC during the Covid-19 emergency in order to identify their future applicability as an ordinary model of oncology patient management. Methodology: Application of ministerial recommendations, of the Piedmont and Aosta Valley Oncology Network and of the main scientific societies on the management of oncological patients during the pandemic and in phase 2. Results: During the pandemic, organisational models and pathways were adopted that ensured continuity of care and patient safety and can also be applied in the post-Covid phase. Conclusions: The reorganisation model of Oncology during the Covid-19 emergency was effective and some of the pathways adopted may constitute an ordinary tool of activity.
Downloads
Download data is not yet available.
Citations
How to Cite
Post-COVID oncology. (2020). Working Paper of Public Health, 8(1). https://doi.org/10.4081/wpph.2020.9245
Most read articles by the same author(s)
- F. Grosso, A. Kasa, G. Gallizzi, S. Crivellari, D. Degiovanni, E. Ponte, S. Zai, Malignant pleural mesothelioma in the elderly patient. Retrospective study in the centers of Alessandria and Casale Monferrato , Working Paper of Public Health: Vol. 5 (2016)
- G. Gallizzi, S. Crivellari, A. Roveta, A. Muzio, S. Zai, G. Taverna, A. Aurelio, R. Libener, N. Mariani, M. D’Angelo, D. Degiovanni, F. Grosso, Pleural sarcomatoid mesothelioma: clinical-pathological and survival analysis of a series of 80 cases, multicentre retrospective study , Working Paper of Public Health: Vol. 4 (2015)
- F. Grosso, V. Maglione, A. Fozza, M. Rossi, I. De Martino, L. Randi, E. Guasco, V. Fusco, P. Franzone, F. Musante, G. Spinoglio, Terapia neoadiuvante e Total Mesorectal Excision (TME) con approccio mininvasivo per cancro del retto: analisi dei risultati di una serie consecutiva di 117 pazienti trattati in un unico centro , Working Paper of Public Health: Vol. 1 (2012)
- F. Grosso, S. Crivellari, N.F. Trincheri, F. Ugo, M.G. Candeo, A. Pertino, S. Zai, A. Aurelio, N. Mariani, M. Mancuso, Giant cell tumour of bone: a case report , Working Paper of Public Health: Vol. 4 (2015)
- S. Crivellari, F. Ugo, N. Trincheri, A. Roveta, L. Randi, R. Libener, G. Ferretti, D. Degiovanni, S. Zai, F. Grosso, Chemotherapy and alternative therapies for malignant pleural mesothelioma , Working Paper of Public Health: Vol. 4 (2015)
- P. Franzone, F. Grosso, L. Todisco, L. Berretta, S. Zai, A. Aurelio, G. Pozzi, A. Orecchia, M. Mancuso, F. Musante, G. Ferretti, Role of radiotherapy in the treatment of malignant pleural mesothelioma , Working Paper of Public Health: Vol. 3 (2014)
- F. Grosso, S. Crivellari, G. Gallizzi, N.F. Trincheri, S. Zai, D. Degiovanni, Malignant pleural mesothelioma: review and analysis of clinical studies presented at ASCO 2015 , Working Paper of Public Health: Vol. 4 (2015)
- V. Fusco, A. Baraldi, A. Fasciolo, M. Rapetti, I. De Martino, L. Randi, A. Bedogni, A. Agrillo, G. Campisi, Osteonecrosis of jaw (onj): impact of italian patients, and role of italian physicians, dentists, and researchers in the growing evidence of a “new” disease , Working Paper of Public Health: Vol. 1 (2012)
- S. Zai, P. Guglielmini, P.L. Piovano, R. Cevoli, A. Aurelio, F. Grosso, Attività di sunitinib in un caso di carcinoma renale dei dotti di Bellini , Working Paper of Public Health: Vol. 2 (2013)
- P. Guglielmini, A. Serao, S. Zai, P.L. Piovano, F. Grosso, Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma , Working Paper of Public Health: Vol. 4 (2015)
